immune reaction to tirzepatide 10 Benefits of Tirzepatide reduces food intake and

NICE technology appraisal TA875 (2023) recommends semaglutide 2.4 mg (Wegovy) as an adjunct to a reduced-calorie diet and increased physical activity for adults with a BMI of 35 kg/m or above (or 3034.9 kg/m in certain circumstances) alongside at least one weight-related comorbidity, when initiated within specialist weight management services

Do not stop the medication cold turkey, as it may cause your blood sugar to increase

Accidentally leaving semaglutide out overnight creates comparable potency concerns, and using expired semaglutide carries similar risks

Or explore alternative tirzepatide delivery methods that may reduce GI side effects

Rarer safety concerns that need consideration in older adults are hypoglycaemia, dehydration, acute kidney injury, gallstones, and acute pancreatitis